All posts tagged
What Happened to the Smart Contact Lens for Diabetics?
Novo Nordisk will open a €135M Diabetes R&D Center at Oxford University
Needle-free Treatments for Autoimmune Disorders from Switzerland
Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin
Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II
Top European VC and CRO fund Young Metabolic Disease Biotech
These are our 10 Most Read Biotech Articles of 2016
What does ‘Anti-Aging Treatment’ mean in Biotech?
Needle-Free Diabetes Monitoring: Interview with the Co-Founder of GlucoWise
Can Biotech Stop the Diabetes Epidemic? Reviewing the Hottest Technology
A €103M Target to Reduce Drug Dosage with a Slow-Release Tech
Sanofi & Google Joint Venture could Revolutionize Diabetes
Labiotech UG, All Rights Reserved -
Send this to friend